BRIM Biotechnology, Inc. engages in the research and development of treatment drugs. It offers medicines for dry eye syndrome, corneal damage repair, neurotrophic keratitis, and osteoarthritis. The company was founded by Hai Shan Jian and Wen Chi Lee on July 31, 2013 and is headquartered in Taipei, Taiwan.